Παραπομπή σε μορφή APA (7η εκδ.)

Ramjanee, S., Robertson, J., Franke-Fayard, B., Sinha, R., Waters, A., Janse, C., . . . Sinden, R. (2007). The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.

Παραπομπή σε μορφή Chicago (17η εκδ.)

Ramjanee, S., et al. The Use of Transgenic Plasmodium Berghei Expressing the Plasmodium Vivax Antigen P25 to Determine the Transmission-blocking Activity of Sera from Malaria Vaccine Trials. 2007.

Παραπομπή σε μορφή MLA (9th εκδ.)

Ramjanee, S., et al. The Use of Transgenic Plasmodium Berghei Expressing the Plasmodium Vivax Antigen P25 to Determine the Transmission-blocking Activity of Sera from Malaria Vaccine Trials. 2007.